SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-24-011455
Filing Date
2024-02-08
Accepted
2024-02-08 12:48:56
Documents
1
Group Members
BRIO CAPITAL MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO SCHEDULE 13G ea193199-13ga6brio_sigyn.htm SC 13G/A 60355
  Complete submission text file 0001213900-24-011455.txt   62289
Mailing Address C/O BRIO CAPITAL MANAGEMENT LLC 100 MERRICK ROAD SUITE 401W ROCKVILLE CENTRE NY 11570
Business Address C/O BRIO CAPITAL MANAGEMENT LLC 100 MERRICK ROAD SUITE 401W ROCKVILLE CENTRE NY 11570 516-536-0500
Brio Capital Master Fund Ltd. (Filed by) CIK: 0001560894 (see all company filings)

IRS No.: 981072321 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Subject) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89792 | Film No.: 24607983
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)